Results From the DoPING-HFpEF Trial: A Double Blind, Placebo-Controlled Randomized Cross-Over Trial Investigating Trimetazidine in Heart Failure With Preserved Ejection Fraction

被引:0
|
作者
de Bovenkamp, Arno A. Van
Bakermans, Adrianus J. J.
Geurkink, Kiki J.
Oosterveer, Frank T.
De Man, Frances S.
Kok, Wouter E.
Nederveen, Aart J.
van Rossum, Albert C.
Handoko, M. Louis L.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A12368
引用
收藏
页数:3
相关论文
共 50 条
  • [21] EXTENDED RELEASE ORAL MILRINONE FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION: A RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED TRIAL
    Nanayakkara, Shane
    Byrne, Melissa
    Mak, Vivian
    Crannitch, Karina
    Evans, Shona
    Kaye, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 950 - 950
  • [22] Economic impact of heart failure with preserved ejection fraction: Insights from the prospective, randomized placebo-controlled ALDO-DHF trial
    Hashemi, D. Djawid
    Dettmann, L.
    Trippel, T. D.
    Bobenko, A.
    Gelbrich, G.
    Lindhorst, R.
    Duengen, H. D.
    Wachter, R.
    Hasenfuss, G.
    Pieske, B.
    Edelmann, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 155 - 155
  • [23] Randomized Double-Blind Trial of Enalapril in Older Patients With Heart Failure and Preserved Ejection Fraction
    Kitzman, Dalane W.
    Hundley, W. Gregory
    Brubaker, Peter H.
    Morgan, Timothy M.
    Moore, J. Brian
    Stewart, Kathryn P.
    Little, William C.
    CIRCULATION-HEART FAILURE, 2010, 3 (04) : 477 - 485
  • [24] Randomized double-blind placebocontrolled trial of perhexiline in heart failure with preserved ejection fraction syndrome
    Singh, Satnam
    Beadle, Roger
    Cameron, Donnie
    Rudd, Amelia
    Bruce, Maggie
    Jagpal, Baljit
    Schwarz, Konstantin
    Brindley, Gemma
    Mckiddie, Fergus
    Lang, Chim
    Dawson, Dana
    Frenneaux, Michael
    FUTURE CARDIOLOGY, 2014, 10 (06) : 693 - 698
  • [25] Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomised placebo-controlled trial
    Komajda, M. Michel
    Isnard, R.
    Cohen-Solal, A.
    Metra, M.
    Pieske, B.
    Ponikowski, P.
    Voors, A. A.
    Dominjon, F.
    Henon-Goburdhun, C.
    Pannaux, M.
    Bohm, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 350 - 350
  • [26] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [27] Ubiquinol Improves Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Single Center, Randomized Double-Blind Placebo-Controlled Cross-Over Study
    Kawashima, Chika
    Matsuzawa, Yasushi
    Akiyama, Eiichi
    Sato, Ryosuke
    Konishi, Masaaki
    Suzuki, Hiroyuki
    Kimura, Yuichiro
    Ebina, Toshiaki
    Kosuge, Masami
    Hibi, Kiyoshi
    Iwahashi, Noriaki
    Maejima, Nobuhiko
    Kimura, Kazuo
    CIRCULATION, 2016, 134
  • [28] Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
    Segev, Aviv
    Evans, Anthony
    Hodsoll, John
    Whiskey, Eromona
    Sheriff, Rebecca S.
    Shergill, Sukhi
    MacCabe, James H.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 101 - 107
  • [29] Ubiquinol Improves Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Single Center, Randomized Double-Blind Placebo-Controlled Cross-Over Study
    Kawashima, Chika
    Matsuzawa, Yasushi
    Akiyama, Eiichi
    Sato, Ryosuke
    Konishi, Masaaki
    Suzuki, Hiroyuki
    Kimura, Yuichiro
    Ebina, Toshiaki
    Kosuge, Masami
    Hibi, Kiyoshi
    Iwahashi, Noriaki
    Maejima, Nobuhiko
    Kimura, Kazuo
    CIRCULATION, 2016, 134
  • [30] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Otmar Bayer
    Tatiana Brémová
    Michael Strupp
    Katharina Hüfner
    Journal of Neurology, 2018, 265 : 291 - 298